Search

everythinglearnresearchcommunity

for

Search:↓

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Minoxidil alone is as effective as the combination but has fewer side effects.

Oral minoxidil effectively treats female pattern hair loss and is a good alternative to topical minoxidil.

Menopause reduces skin fat, but treatments like magnolol and PLLA-SCA can help restore skin health.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Minoxidil effectively controls blood pressure in severe cases, but has serious side effects and causes hair growth in women.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New compounds were made that are promising for prostate cancer therapy.

The document concludes that thyroid disorders in children require specific treatments and monitoring, and educational resources are available for further information.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Low-dose oral minoxidil is being revisited as a promising hair loss treatment.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Cyclosporin and minoxidil promote hair growth.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.